Experimental Oncology : Impact Factor & More
eISSN: 2312-8852pISSN: 1812-9269
Share this on:
Key Metrics
CiteScore 
1.6
SJR
Q4Oncology
SNIP
0.34
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Experimental Oncology
Experimental Oncology Journal Specifications
| Overview | |
| Publisher | INST EXP PATHOL ONCOL RADIOBIOL |
| Frequency | Quarterly |
| General Details | |
| Frequency | Quarterly |
| Website URL | Visit website |
View less
Planning to publish in Experimental Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Experimental Oncology
Clinical Case of Inferior Vena Cava Leiomyoma in a Patient with Thrombocytopenia.
- 14 Jun 2026
- Experimental oncology
A Case Report: A Rare Casr Mutation Associated with HER2-Positive Breast Cancer.
- 14 Jun 2026
- Experimental oncology
ROLE OF miR-26b-5p AND miR-186-5p IN BREAST CANCER PATIENTS OF YOUNG AGE: CLINICAL ASSOCIATIONS AND RELATION TO ANTHRACYCLINE RESPONSE.
- 5 Mar 2026
- Experimental oncology
SPIKE PROTEIN OF SARS-COV-2 INCREASES CXCR4 EXPRESSION AND MIGRATION OF BREAST CANCER CELLS IN VITRO.
- 5 Mar 2026
- Experimental oncology
NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES.
- 5 Mar 2026
- Experimental oncology
INTRA-ARTERIAL CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER: A LITERATURE REVIEW.
- 5 Mar 2026
- Experimental oncology
Clinical Case of Inferior Vena Cava Leiomyoma in a Patient with Thrombocytopenia.
- 14 Jun 2026
- Experimental oncology
A Case Report: A Rare Casr Mutation Associated with HER2-Positive Breast Cancer.
- 14 Jun 2026
- Experimental oncology
ROLE OF miR-26b-5p AND miR-186-5p IN BREAST CANCER PATIENTS OF YOUNG AGE: CLINICAL ASSOCIATIONS AND RELATION TO ANTHRACYCLINE RESPONSE.
- 5 Mar 2026
- Experimental oncology
SPIKE PROTEIN OF SARS-COV-2 INCREASES CXCR4 EXPRESSION AND MIGRATION OF BREAST CANCER CELLS IN VITRO.
- 5 Mar 2026
- Experimental oncology
NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES.
- 5 Mar 2026
- Experimental oncology
INTRA-ARTERIAL CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER: A LITERATURE REVIEW.
- 5 Mar 2026
- Experimental oncology
FAQs on Experimental Oncology
What is the publishing frequency of Experimental Oncology? 
How many articles did Experimental Oncology publish last year?
What is the eISSN & pISSN for Experimental Oncology?
What is Citescore for Experimental Oncology?
What is SNIP score for Experimental Oncology?
What is the SJR for Experimental Oncology?
Who is the publisher of Experimental Oncology?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations